nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PLA2G4A—Carbachol—glaucoma	0.609	1	CbGbCtD
Niflumic Acid—PTGS2—glaucoma	0.328	1	CbGaD
Niflumic Acid—PLA2G4A—Pindolol—Levobunolol—glaucoma	0.00114	0.276	CbGdCrCtD
Niflumic Acid—PLA2G4A—Pindolol—Carteolol—glaucoma	0.00114	0.276	CbGdCrCtD
Niflumic Acid—Floctafenine—PTGS2—glaucoma	0.0011	0.719	CrCbGaD
Niflumic Acid—PLA2G4A—Pindolol—Metipranolol—glaucoma	0.00108	0.263	CbGdCrCtD
Niflumic Acid—PLA2G4A—Pindolol—Betaxolol—glaucoma	0.000758	0.184	CbGdCrCtD
Niflumic Acid—Mefenamic acid—PTGS2—glaucoma	0.00043	0.281	CrCbGaD
Niflumic Acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000211	0.0037	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Arachidonic acid metabolism—PTGS2—glaucoma	0.000208	0.00364	CbGpPWpGaD
Niflumic Acid—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000205	0.0036	CbGpPWpGaD
Niflumic Acid—UGT1A9—PPARA activates gene expression—ABCA1—glaucoma	0.000203	0.00356	CbGpPWpGaD
Niflumic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000199	0.00349	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000198	0.00347	CbGpPWpGaD
Niflumic Acid—UGT1A9—Phase II conjugation—GSTM1—glaucoma	0.000194	0.0034	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—MMP2—glaucoma	0.000194	0.0034	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NARFL—glaucoma	0.000194	0.0034	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CA5A—glaucoma	0.000194	0.0034	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000193	0.00339	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—TGFB2—glaucoma	0.000191	0.00334	CbGpPWpGaD
Niflumic Acid—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.00019	0.00333	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—NOS3—glaucoma	0.000182	0.00319	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—GSTT1—glaucoma	0.000178	0.00313	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000176	0.00309	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000174	0.00305	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000165	0.00289	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000164	0.00288	CbGpPWpGaD
Niflumic Acid—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000163	0.00286	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CA1—glaucoma	0.000162	0.00284	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00016	0.00281	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet homeostasis—NOS3—glaucoma	0.000159	0.00279	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000159	0.00278	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000157	0.00276	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CTSA—glaucoma	0.000157	0.00275	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CA5A—glaucoma	0.000151	0.00264	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NARFL—glaucoma	0.000151	0.00264	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CA2—glaucoma	0.000148	0.0026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—AGE/RAGE pathway—MMP9—glaucoma	0.000146	0.00256	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000145	0.00255	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000145	0.00254	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000145	0.00254	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000144	0.00253	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—CYP1B1—glaucoma	0.000142	0.00249	CbGpPWpGaD
Niflumic Acid—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.00014	0.00246	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metapathway biotransformation—CYP1B1—glaucoma	0.00014	0.00246	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.00014	0.00246	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.00014	0.00245	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000137	0.0024	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000133	0.00233	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000133	0.00233	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000132	0.00232	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.00013	0.00229	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—GSTM1—glaucoma	0.000129	0.00227	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000125	0.00219	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NARFL—glaucoma	0.000125	0.00219	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CA5A—glaucoma	0.000125	0.00219	CbGpPWpGaD
Niflumic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000124	0.00218	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.00012	0.0021	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000116	0.00204	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—CYP1B1—glaucoma	0.000116	0.00203	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—GSTM1—glaucoma	0.000114	0.00199	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000113	0.00198	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000113	0.00198	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—OPN4—glaucoma	0.000112	0.00197	CbGpPWpGaD
Niflumic Acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000112	0.00196	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metapathway biotransformation—GSTM1—glaucoma	0.000112	0.00196	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.000111	0.00195	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB2—glaucoma	0.000109	0.00192	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000108	0.0019	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—TXN—glaucoma	0.000104	0.00183	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—BDNF—glaucoma	0.000104	0.00182	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000104	0.00182	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CA5A—glaucoma	0.000102	0.00179	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NARFL—glaucoma	0.000102	0.00179	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PTGFR—glaucoma	0.000101	0.00177	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL1A—glaucoma	9.99e-05	0.00175	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	9.66e-05	0.00169	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LRP12—glaucoma	9.56e-05	0.00168	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.52e-05	0.00167	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CA1—glaucoma	9.47e-05	0.00166	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.43e-05	0.00165	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	9.38e-05	0.00164	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—GSTM1—glaucoma	9.26e-05	0.00162	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CTSA—glaucoma	9.17e-05	0.00161	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	8.92e-05	0.00156	CbGpPWpGaD
Niflumic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	8.82e-05	0.00155	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—FN1—glaucoma	8.7e-05	0.00153	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CA2—glaucoma	8.66e-05	0.00152	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.59e-05	0.00151	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB2—glaucoma	8.51e-05	0.00149	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—SOD1—glaucoma	8.29e-05	0.00145	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTT1—glaucoma	8.09e-05	0.00142	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CA5A—glaucoma	8.09e-05	0.00142	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NARFL—glaucoma	8.09e-05	0.00142	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	8.04e-05	0.00141	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	7.86e-05	0.00138	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	7.73e-05	0.00136	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	7.52e-05	0.00132	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CA1—glaucoma	7.37e-05	0.00129	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LRP12—glaucoma	7.32e-05	0.00128	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CTSA—glaucoma	7.13e-05	0.00125	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.13e-05	0.00125	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	7.11e-05	0.00125	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.08e-05	0.00124	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	6.96e-05	0.00122	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CA2—glaucoma	6.74e-05	0.00118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.73e-05	0.00118	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—OPN4—glaucoma	6.62e-05	0.00116	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.58e-05	0.00115	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.58e-05	0.00115	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.52e-05	0.00114	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SOD1—glaucoma	6.45e-05	0.00113	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP1B1—glaucoma	6.44e-05	0.00113	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ABCA1—glaucoma	6.44e-05	0.00113	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—MMP1—glaucoma	6.32e-05	0.00111	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HEYL—glaucoma	6.16e-05	0.00108	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—TXN—glaucoma	6.1e-05	0.00107	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CA1—glaucoma	6.1e-05	0.00107	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—CAV1—glaucoma	6.06e-05	0.00106	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.06e-05	0.00106	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	6.02e-05	0.00106	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTGFR—glaucoma	5.96e-05	0.00105	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CTSA—glaucoma	5.91e-05	0.00104	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—FN1—glaucoma	5.77e-05	0.00101	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.6e-05	0.000982	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CA2—glaucoma	5.58e-05	0.000979	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.46e-05	0.000957	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.46e-05	0.000957	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	5.31e-05	0.00093	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.18e-05	0.000909	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTM1—glaucoma	5.15e-05	0.000903	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—SMO—glaucoma	5.09e-05	0.000893	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	4.98e-05	0.000873	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CA1—glaucoma	4.98e-05	0.000872	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—MMP1—glaucoma	4.92e-05	0.000862	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MMP9—glaucoma	4.91e-05	0.000862	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CTSA—glaucoma	4.82e-05	0.000845	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.8e-05	0.000841	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	4.78e-05	0.000838	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TXN—glaucoma	4.75e-05	0.000832	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTT1—glaucoma	4.73e-05	0.00083	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FGFR1OP—glaucoma	4.72e-05	0.000827	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HEYL—glaucoma	4.72e-05	0.000827	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—CAV1—glaucoma	4.71e-05	0.000826	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RPTOR—glaucoma	4.67e-05	0.000818	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—NOS3—glaucoma	4.58e-05	0.000804	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—glaucoma	4.55e-05	0.000798	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CA2—glaucoma	4.55e-05	0.000798	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NCK2—glaucoma	4.52e-05	0.000793	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—FN1—glaucoma	4.49e-05	0.000787	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.45e-05	0.00078	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.45e-05	0.00078	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.33e-05	0.000759	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.29e-05	0.000752	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—APOE—glaucoma	4.24e-05	0.000743	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.23e-05	0.000742	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CAV1—glaucoma	4.2e-05	0.000736	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CA1—glaucoma	3.95e-05	0.000693	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TXN—glaucoma	3.93e-05	0.00069	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HDAC9—glaucoma	3.84e-05	0.000674	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CTSA—glaucoma	3.83e-05	0.000671	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—glaucoma	3.78e-05	0.000663	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP1B1—glaucoma	3.77e-05	0.000661	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ABCA1—glaucoma	3.77e-05	0.000661	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTT1—glaucoma	3.68e-05	0.000645	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CA2—glaucoma	3.61e-05	0.000633	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.61e-05	0.000633	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.59e-05	0.000629	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NOS3—glaucoma	3.56e-05	0.000625	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.56e-05	0.000623	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.53e-05	0.000619	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.53e-05	0.000619	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EDN1—glaucoma	3.36e-05	0.000589	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—glaucoma	3.33e-05	0.000585	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—VEGFA—glaucoma	3.3e-05	0.000579	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TXN—glaucoma	3.21e-05	0.000562	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—NOS3—glaucoma	3.18e-05	0.000557	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTT1—glaucoma	3.05e-05	0.000535	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTM1—glaucoma	3.01e-05	0.000529	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SMO—glaucoma	3.01e-05	0.000527	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3e-05	0.000526	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.97e-05	0.00052	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HDAC9—glaucoma	2.94e-05	0.000516	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—C3—glaucoma	2.93e-05	0.000514	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ABCA1—glaucoma	2.93e-05	0.000514	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP1B1—glaucoma	2.93e-05	0.000514	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.93e-05	0.000513	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—glaucoma	2.9e-05	0.000509	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.9e-05	0.000508	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NTRK2—glaucoma	2.75e-05	0.000482	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—glaucoma	2.66e-05	0.000467	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.57e-05	0.000451	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—glaucoma	2.57e-05	0.00045	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TXN—glaucoma	2.55e-05	0.000446	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—glaucoma	2.49e-05	0.000437	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTT1—glaucoma	2.49e-05	0.000436	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOE—glaucoma	2.48e-05	0.000435	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.46e-05	0.000431	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CAV1—glaucoma	2.46e-05	0.000431	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ABCA1—glaucoma	2.43e-05	0.000426	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP1B1—glaucoma	2.43e-05	0.000426	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NGFR—glaucoma	2.36e-05	0.000414	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—glaucoma	2.34e-05	0.000411	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.32e-05	0.000407	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.3e-05	0.000403	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.27e-05	0.000398	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NTRK1—glaucoma	2.24e-05	0.000393	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—glaucoma	2.07e-05	0.000363	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN2B—glaucoma	2.07e-05	0.000362	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2e-05	0.000351	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDN1—glaucoma	1.98e-05	0.000348	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ABCA1—glaucoma	1.98e-05	0.000347	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP1B1—glaucoma	1.98e-05	0.000347	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTT1—glaucoma	1.97e-05	0.000346	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—glaucoma	1.94e-05	0.000341	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—glaucoma	1.94e-05	0.00034	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOE—glaucoma	1.93e-05	0.000338	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CAV1—glaucoma	1.91e-05	0.000335	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NOS3—glaucoma	1.86e-05	0.000326	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NGF—glaucoma	1.82e-05	0.00032	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—C3—glaucoma	1.73e-05	0.000304	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—glaucoma	1.72e-05	0.000301	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—glaucoma	1.7e-05	0.000298	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOE—glaucoma	1.61e-05	0.000283	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOE—glaucoma	1.6e-05	0.00028	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CAV1—glaucoma	1.6e-05	0.00028	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CAV1—glaucoma	1.58e-05	0.000278	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—glaucoma	1.58e-05	0.000278	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN2B—glaucoma	1.58e-05	0.000277	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP1B1—glaucoma	1.57e-05	0.000276	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ABCA1—glaucoma	1.57e-05	0.000276	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FN1—glaucoma	1.52e-05	0.000267	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—BAD—glaucoma	1.5e-05	0.000264	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NOS3—glaucoma	1.44e-05	0.000253	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—glaucoma	1.4e-05	0.000245	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—glaucoma	1.33e-05	0.000233	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—glaucoma	1.32e-05	0.000232	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOE—glaucoma	1.3e-05	0.000228	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CAV1—glaucoma	1.29e-05	0.000226	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—glaucoma	1.26e-05	0.00022	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOE—glaucoma	1.23e-05	0.000217	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CAV1—glaucoma	1.22e-05	0.000215	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOS3—glaucoma	1.21e-05	0.000212	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NOS3—glaucoma	1.2e-05	0.00021	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—BAD—glaucoma	1.15e-05	0.000202	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—glaucoma	1.11e-05	0.000195	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—glaucoma	1.1e-05	0.000192	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN1B—glaucoma	1.05e-05	0.000184	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOE—glaucoma	1.03e-05	0.000181	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CAV1—glaucoma	1.02e-05	0.00018	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NOS3—glaucoma	9.76e-06	0.000171	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—glaucoma	9.69e-06	0.00017	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS3—glaucoma	9.25e-06	0.000162	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—glaucoma	8.93e-06	0.000157	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—glaucoma	8.7e-06	0.000153	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN1B—glaucoma	8.01e-06	0.000141	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NOS3—glaucoma	7.75e-06	0.000136	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—glaucoma	6.58e-06	0.000115	CbGpPWpGaD
